Results 31 to 40 of about 28,749 (179)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa +3 more
wiley +1 more source
Diabetes mellitus, chronic pancreatitis and primary hyperparathyroidism: is there a connection?
Сахарный диабет, 2019 Hyperparathyroidism is a relatively frequent condition characterized by hypersecretion of parathyroid hormone. There are several forms of primary hyperparathyroidism. Each form affects its target region.
Anna M. Gorbacheva, Nataliya V. Zaytseva
doaj +1 more source
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis
Arthritis &Rheumatology, EarlyView.Objective Transition from long‐term denosumab (Dmab) to parathyroid hormone‐analogs or romosozumab (Romo) might expose patients to the risk of the so‐called rebound phenomenon. Adding Romo to Dmab might represent an option in patients experiencing a fracture while on Dmab.
Giovanni Adami +10 more
wiley +1 more source
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
British Journal of Clinical Pharmacology, EarlyView.Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
Primary hyperparathyroidism clinical features on endocrinology in-patients clinic
Терапевтический архив, 2018 Aim. The analysis clinical features of primary hyperparathyroidism on endocrinology in-patients clinic. Materials and methods. Open retrospective study, included data of patients who were hospitalized at Kirov Regional Hospital with primary ...
I E Sapozhnikova
doaj +1 more source
European Journal of Case Reports in Internal MedicineSodium-glucose cotransporter-2 (SGLT2) inhibitors have complex interactions with bone metabolism, including an increase in parathyroid hormone (PTH) levels.
Christodoulos Dolapsakis +2 more
doaj +1 more source
Management of post‐implant fibrous dysplasia in the maxilla: A case study
Clinical Advances in Periodontics, EarlyView.Abstract Background Fibrous dysplasia is generally rare, and even rarer in older adults. Special care is needed when altering the alveolar bone in these cases, especially if an implant is involved. This case study highlights such a scenario. Methods This case study details the experience of a 63‐year‐old African American female who presented with a ...
Yousef Taha Y. Amrou +4 more
wiley +1 more source
Clinical and morphological features of diagnosis and treatment of various forms of primary hyperparathyorosis [PDF]
Саратовский научно-медицинский журнал, 2017 Objective: optimization of the diagnostic algorithm and treatment methods for different clinical forms of the primary hyperparathyroidism. Material and Methods.
Kovalenko Yu.V. +4 more
doaj
International Journal of Clinical Practice, 1988 The incidence of primary hyperparathyroidism amongst the elderly has increased during the last decade. Recent studies show that the incidence has risen to 277 per million population after the introduction of automated techniques for measuring the serum calcium.
B K, Mondal, R L, Biswas, K N, Mondal
openaire +2 more sources
Women with epilepsy: Evidence‐based counseling across the lifespan
Epilepsia, EarlyView.Abstract Women with epilepsy (WWE) encounter distinct and evolving challenges across the lifespan that require clinical management extending beyond seizure control alone. Although awareness of sex‐specific aspects of epilepsy has increased, important gaps remain in their integration into routine care.
Barbara Tettenborn +7 more
wiley +1 more source